Noah Weisleder received his B.S. degree in biotechnology and molecular biology from Worcester Polytechnic Institute and his Ph.D. degree in cell biology from Baylor College of Medicine, Houston, TX, USA. He conducted his postdoctoral studies at Robert Wood Johnson Medical School and is now an Associate Professor at The Ohio State University. During this time, Weisleder has published dozens of peer-reviewed publications or book chapters in the fields of muscle physiology, cardiovascular disease, cytoskeletal dynamics, membrane repair, and cellular calcium homeostasis in normal physiology and disease states. He has chaired sessions at national and international meetings on muscle physiology and metabolism and has been invited to present his research at several international conferences. Additionally, Weisleder is an inventor of six published US patent applications and numerous international patent applications. These inventions became the basis for the formation of TRIM-edicine, a biotechnology company developing protein therapeutics targeting regenerative medicine applications, where Weisleder is a Cofounder and a Chief Scientific Officer. At TRIM-edicine, Weisleder oversees all developmental programs and manages partnerships with established pharmaceutical companies. He has received a fellowship from the American Heart Association, a Pathway to the Independence Award from the National Institutes of Health, and the 2011 Kauffman Foundation Outstanding Postdoctoral Entrepreneur Award.
Biography Updated on 29 November 2012